Asthma Screening Study
Future Participant Registry 

Screening Protocol 

IRB No. HUM00211543

Investigator Initiated | Lugogo

Proactively evaluate potential subjects with asthma who have expressed interest in participating in clinical asthma research trials at Michigan Medicine.

Studies Currently Enrolling
Therapeutic Trials  

AJAX  

IRB No. HUM00244175

AstraZeneca | D8210C00003 | Lugogo

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AZD4604 Twice Daily for Twelve Weeks in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

ATLAS 

IRB No. HUM00206820

Sanofi | LPS16676 | Lugogo

Study assessing the long-term effect of Dupilumab (Dupixent) on prevention of lung function decline in patients with uncontrolled moderate to severe asthma.

CHINOOK 

IRB No. HUM00196809

AstraZeneca | D3250C00059 | Lugogo

Study designed to evaluate the effect of Benralizumab (Fasenra) on patients with uncontrolled severe, eosinophilic asthma despite a high dose ICS-based treatment regimen with an eosinophilic phenotype. 

Joining one of our study trials may be right for one of your patients.

Contact Us & Get Involved

 miasthmaresearch@med.umich.edu 

(734) 764-5530

Thank you for your consideration and referrals.